Keep up to date with the latest developments at CDISC and follow our news feeds!
28 Mar 2018

Austin, TX – 28 MAR 2018 – The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce it has been awarded a grant in the amount of $1,000,000 by The Leona M. and Harry B. Helmsley Charitable Trust to develop Type 1 Diabetes (T1D)-related data standards.

18 Jan 2018

Austin, TX18 January 2018– The Clinical Data Interchange Standards Consortium (CDISC) today announced Chris Decker and Pam Howard have joined its Board of Directors to serve three-year terms, which began 1 January 2018.


19 Dec 2017 | David Bobbitt, CEO, CDISC |

18 Oct 2017

TUCSON, Ariz., and AUSTIN, Texas – October 18, 2017 – Critical Path Institute (C-Path) and The Clinical Data Interchange Standards Consortium (CDISC) announce the open availability of a Duchenne Muscular Dystrophy Therapeutic Area User Guide (TAUG-DMD v1.0), which describes the most common clinical concepts relevant to Duchenne studies using the CDISC standard format. This format allows datasets from different sources to be compared or combined for data collection, sharing, and analyses.

20 Sep 2017

AUSTIN, Texas – 20 SEP 2017 – The Clinical Data Interchange Standards Consortium (CDISC) and Cohen Veterans Bioscience announce the availability of a Post Traumatic Stress Disorder Therapeutic Area User Guide (TAUG-PTSD) for public review.

7 Sep 2017 | Nicole Harmon | Association of Medical Research Charities (AMRC)

11 Sep 2017

TUCSON, AZ, NEW YORK, NY, and AUSTIN, TX – September 11, 2017Critical Path Institute (C-Path), CHDI Foundation, Inc. (CHDI), and The Clinical Data Interchange Standards Consortium (CDISC) announce the availability of a draft Huntington's disease (HD) Therapeutic Area User Guide (TAUG-HD v1.0) for public review. The TAUG-HD v1.0 describes how HD clinical data should be recorded in a standardized database to establish common best practices across the healthcare industry for the recording, reporting, and sharing of clinically relevant disease-specific metadata, research data, and patient information. Use of the standard will allow the HD research community to compare and contrast data from different studies more easily and with more scientific rigor, and will make it easier for researchers to understand natural history, biomarker, and trial data in the future. It will also facilitate regulatory submissions for novel therapeutics.

7 Sep 2017

Austin, TX – 07 SEP 2017 – The Clinical Data Interchange Standards Consortium (CDISC) and the Pharmaceutical Users Software Exchange (PhUSE) announced today an evolution of their partnership to strengthen their work around the development and implementation of beginning-to-end standards.

15 Aug 2017

Austin, TX – 15 AUG 2017 – According to the World Health Organization, prostate cancer is one of the five most common types of cancer to affect men globally. In an effort to improve research for prostate cancer, the Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the release of a new Therapeutic Area (TA) Standard for Prostate Cancer in the form of a User Guide for data managers, statisticians, programmers and study managers. In announcing the new CDISC Therapeutic Area User Guide, freely available on the CDISC website, President and CEO David R. Bobbitt stated, “CDISC’s community has built this Therapeutic Area Standard to provide research professionals with guidance on how to represent patient data in clinical research to improve quality, efficiency and cost effectiveness, fostering smarter research to discover new treatments. By building data standards for researchers, we give them a more rapid start up and the capacity to share data with collaborators with less effort.”